What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later

OBJECTIVE: The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the most rapid response and scale-up in vaccine and therapeutic development in history. We highlight the history of these amazing achievements with a focu...

Descripción completa

Detalles Bibliográficos
Autores principales: Copaescu, Ana M., Rosa Duque, Jaime S., Phillips, Elizabeth Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979618/
https://www.ncbi.nlm.nih.gov/pubmed/35390476
http://dx.doi.org/10.1016/j.anai.2022.03.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979618/
https://www.ncbi.nlm.nih.gov/pubmed/35390476
http://dx.doi.org/10.1016/j.anai.2022.03.030

Ejemplares similares